Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Jun;85(6):645–651. doi: 10.1111/j.1349-7006.1994.tb02408.x

Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cells in vitro: Association with the Induction of Apoptosis in Leukemia HL‐60 Cells

Yongkui Jing 1, Hidekazu Ohizumi 1, Nobuko Kawazoe 1, Sachiko Hashimoto 1, Yutaka Masuda 1, Shigeo Nakajo 1, Takemi Yoshida 2, Yukio Kuroiwa 3, Kazuyasu Nakaya 1,✉
PMCID: PMC5919529  PMID: 8063619

Abstract

We found that bufalin, an active principle of the Chinese medicine chan'su, has selective inhibitory effects on the growth of various human cancer cells. In order to examine whether the growth‐inhibitory effect of bufalin on human cancer cells is associated with apoptosis, human leukemia cells were treated with bufalin. HL‐60, ML1, and U937 leukemia cells treated with bufalin at 10−8M and above had condensed and fragmented nuclei. Flow cytometric analysis of these cells treated with bufalin showed fragmented DNA smaller than that of the G1 phase. DNA of HL‐60 cells treated with bufalin showed a ladder pattern characteristic of apoptosis, as analyzed by agarose gel electrophoretic analysis. DNA synthesis and topoisomerase II activity of HL‐60 cells were markedly inhibited as the concentration of bufalin was increased. The concentration needed for inducing apoptosis of HL‐60 cells was 10−8M, which is comparable to that of camptothecin, but lower than those of other antitumor drugs such as cisplatin, VP16 and all‐trans retinoic acid. Apoptosis was not observed when human mononuclear and polymorphonuclear cells were treated with 10−6M bufalin for 24 h. These results indicate the association of the growth‐inhibitory effect of bufalin with the induction of apoptosis, at least in HL‐60 cells, and suggest the usefulness of bufalin for differentiation‐apoptosis‐inducing therapy for cancer.

Keywords: Bufalin, Antitumor, Apoptosis, Leukemia, DNA fragmentation

Full Text

The Full Text of this article is available as a PDF (440.8 KB).

REFERENCES

  • 1. ) Chou , S. , Kaneko , M. , Nakaya , K. and Nakamura , Y.Induction of differentiation of human and mouse myeloid leukemia cells by camptothecin . Biochem. Biophys. Res. Commun. , 166 , 160 – 167 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Nakaya , K. , Chou , S. , Kaneko , M. and Nakamura , Y.Topoisomerase inhibitors have potent differentiation inducing activity for human and mouse myeloid leukemia cells . Jpn. J. Cancer Res. , 82 , 184 – 191 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. ) Zhang , L. , Nakaya , K. , Yoshida , T. and Kuroiwa , Y.Bufalin as a potent inducer of differentiation of human myeloid leukemia cells . Biochem. Biophys. Res. Commun. , 178 , 686 – 693 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Zhang , L. , Nakaya , K. , Yoshida , T. and Kuroiwa , Y.Induction by bufalin of differentiation of human leukemia cells HL‐60, U937 and ML1 toward macrophage/monocyte‐like cells and its potent synergistic effect on the differ entiation of human leukemia cells in combination with other inducers . Cancer Res. , 52 , 4634 – 4641 ( 1992. ). [PubMed] [Google Scholar]
  • 5. ) Sakai , I. , Tanaka , T. , Osawa , S. , Hashimoto , S. and Nakaya , K.Geranylgeranylacetone used as an antiulcer agent is a potent inducer of differentiation of various human myeloid leukemia cell lines . Biochem. Biophys. Res. Commun. , 191 , 873 – 879 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Jing , Y. , Nakaya , K. and Han , R.Differentiation of promyelocytic leukemia cells HL‐60 induced by daidzein in vitro and in vivo . Anticancer Res. , 13 , 1049 – 1054 ( 1993. ). [PubMed] [Google Scholar]
  • 7. ) Kaufmann , S. H.Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note . Cancer Res. , 49 , 5870 – 5878 ( 1989. ). [PubMed] [Google Scholar]
  • 8. ) Onishi , Y. , Azuma , Y. , Sato , Y. , Mizuno , Y. , Tadakuma , T. and Kizaki , Y.Topoisomerase inhibitors induce apoptosisin thymocytes . Biochim. Biophys. Acta , 1175 , 147 – 154 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Yoshida , A. , Ueda , T. and Nakamura , T.DNA damage and cell killing by camptothecin and its derivative in human leukemia HL‐60 cells . Jpn. J. Cancer Res. , 84 , 566 – 573 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Bertrand , R. , Solary , E. , Jenkins , J. and Pommier , Y.Apoptosis and its modulation in human promyelocytic HL‐60 cells treated with DNA topoisomerase I and II inhibitors . Exp. Cell Res. , 207 , 388 – 397 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Barry , M. A. , Behnke , C. A. and Eastman , A.Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia . Biochem. Pharmacol. , 40 , 2353 – 2362 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Evans , D. L. and Dive , C.Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes . Cancer Res. , 53 , 2133 – 2139 ( 1993. ). [PubMed] [Google Scholar]
  • 13. ) Martin , S. J. , Bradley , J. G. and Cotter , T. G.HL‐60 cells induced to differentiate towards neutrophils subsequently die via apoptosis . Clin. Exp. Immunol. , 79 , 448 – 453 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Unten , S. , Sakagami , H. and Konno , K.Stimulation of granulocytic cell iodination by pine cone antitumor substances . J. Leuk. Biol. , 45 , 166 – 175 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Carmichael , J. , DeGraff , W. G. , Gazdar , A. F. , Minna , J. D. and Michell , J. B.Evaluation of a tetrazolium‐based semiautomated colorimetric assay: assessment of chemosensitivity testing . Cancer Res. , 47 , 936 – 942 ( 1987. ). [PubMed] [Google Scholar]
  • 16. ) Noguchi , P. D. and Browne , W. C.The use of chicken erythrocyte nuclei as a biological standard for flow microfluorometry . J. Histochem. Cytochem. , 26 , 761 – 763 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Martin , S. J. , Lennon , S. V. , Bonham , A. M. and Cotter , T. G.Induction of apoptosis (programmed cell death) in human leukemic HL‐60 cells by inhibition of RNA or protein synthesis . J. Immunol. , 145 , 1859 – 1867 ( 1990. ). [PubMed] [Google Scholar]
  • 18. ) Tricoli , J. V. , Sahai , B. M. , McCormick , P. J. , Jarlinski , S. J. , Bertram , J. S. and Kowalski , D.DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H 10T1/2) cells . Exp. Cell Res. , 158 , 1 – 14 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Barbieri , D. , Troiano , L. , Grassilli , E. , Agnesini , C. , Cristofalo , E. A. , Monti , D. , Capri , M. , Cossarizza , A. and Franceschi , C.Inhibition of apoptosis by zinc: a reap praisal . Biochem. Biophys. Res. Commun. , 187 , 1256 – 1261 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Falcieri , E. , Martelli , A. M. , Bareggi , R. , Cataldi , A. and Cocco , L.The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Molt‐4 cells without concomitant DNA fragmentation . Biochem. Biophys. Res. Commun. , 193 , 19 – 25 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Aller , P. , Rius , C. , Mata , F. , Zorrilla , A. , Cabañas , C. , Bellón , T. and Bernabeu , C.Camptothecin induces differ entiation and stimulates the expression of differentiation‐related genes in U937 human promyelocytic leukemia cells . Cancer Res. , 52 , 1245 – 1251 ( 1992. ). [PubMed] [Google Scholar]
  • 22. ) Solary , E. , Bertrand , R. , Kohn , K. W. and Prommier , Y.Differentiation induction of apoptosis in undifferentiated and differentiated HL‐60 cells by topoisomerase I and II inhibitors . Blood , 81 , 1359 – 1368 ( 1993. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES